Story perspectives
Pharma Giants Withdraw £2bn, Threatening UK Medicine Access
10/2/2025
36 7
1 of 1
Story summary
- Major pharmaceutical firms have withdrawn £2bn in UK investments, threatening access to new medicines.
- Merck canceled a £1bn research facility; AstraZeneca scrapped £450m vaccine lab; Bristol Myers Squibb ended 34 National Health Service (NHS) partnerships.
- NHS England spent £20bn on medicines last year; research indicates branded medicines are overpriced.
- A senior official described threats as sinister; NGOs seek an investigation.
